NivolumabInsulin dependent autoimmune diabetes mellitus: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12279-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：307 / 307

相关论文

共 50 条

[1] NivolumabInsulin dependent diabetes: case report
Reactions Weekly, 2017, 1646 (1) : 250 - 250
[2] NivolumabInsulin dependent diabetes mellitus following off label use: case report
Reactions Weekly, 2019, 1746 (1) : 147 - 147
[3] NivolumabInsulin-dependent diabetes mellitus and immune-related pancreatitis: case report
Reactions Weekly, 2022, 1888 (1) : 285 - 285
[4] Ipilimumab/nivolumabInsulin dependent diabetes mellitus: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 759 - 759
[5] NivolumabInsulin dependent diabetes and diabetic ketoacidosis: case report
Reactions Weekly, 2018, 1688 (1) : 174 - 174
[6] Ipilimumab/nivolumabInsulin-dependent diabetes mellitus
Reactions Weekly, 2024, 2002 (1) : 252 - 252
[7] AntineoplasticsLack of efficacy and autoimmune diabetes mellitus: case report
Reactions Weekly, 2021, 1845 (1) : 57 - 57
[8] NivolumabInsulin dependent diabetes, thyroiditis and hypophysitis
Reactions Weekly, 2024, 2002 (1) : 381 - 381
[9] PembrolizumabThyroid damage, autoimmune diabetes mellitus and diabetic ketoacidosis: case report
Reactions Weekly, 2022, 1934 (1) : 362 - 362
[10] PembrolizumabCheckpoint inhibitor-associated autoimmune diabetes mellitus: case report
Reactions Weekly, 2025, 2040 (1) : 810 - 810

← 1 2 3 4 5 →